OVARIAN CANCER METASTATIC
Clinical trials for OVARIAN CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER METASTATIC trials appear
Sign up with your email to follow new studies for OVARIAN CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug HWK-007 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called HWK-007 in people with advanced solid tumors, including certain ovarian, endometrial, and lung cancers. The drug is designed to target a protein (PTK7) found on cancer cells and deliver a chemotherapy-like payload directly to them. T…
Matched conditions: OVARIAN CANCER METASTATIC
Phase: PHASE1 • Sponsor: Whitehawk Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for aggressive ovarian cancer: targeted drug combo enters trial
Disease control Recruiting nowThis study tests a new drug combination for people with a specific, high-risk type of ovarian cancer that has not yet been treated. The treatment includes a targeted drug (disitamab vedotin) plus standard chemotherapy and a blood-vessel blocker (bevacizumab). After initial treatm…
Matched conditions: OVARIAN CANCER METASTATIC
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated May 18, 2026 12:12 UTC